Health-related quality of life and healthcare utilisation in patients with Parkinson's disease: impact of motor fluctuations and dyskinesias.

PubWeight™: 1.03‹?› | Rank: Top 15%

🔗 View Article (PMID 11735671)

Published in Pharmacoeconomics on January 01, 2001

Authors

R C Dodel1, K Berger, W H Oertel

Author Affiliations

1: Department of Neurology, Philipps-University Marburg, Germany. dodel@mailer.uni-marburg.de

Associated clinical trials:

Sleep Homeostasis in Parkinson's Disease | NCT02200887

Articles citing this

Depression in Parkinson's disease: health risks, etiology, and treatment options. Neuropsychiatr Dis Treat (2008) 1.01

Pharmacotherapy of Parkinson's disease in Germany. J Neurol (2005) 0.96

Development of a Patient Questionnaire to facilitate recognition of motor and non-motor wearing-off in Parkinson's disease. J Neural Transm (Vienna) (2006) 0.94

Continuous levodopa for advanced Parkinson's disease. Neuropsychiatr Dis Treat (2007) 0.92

Costs of Parkinson's disease in a privately insured population. Pharmacoeconomics (2013) 0.87

A novel quality of life instrument for deep brain stimulation in movement disorders. J Neurol Neurosurg Psychiatry (2003) 0.83

The clinical spectrum of levodopa-induced motor complications. J Neurol (2010) 0.83

Assessing self-awareness of dyskinesias in Parkinson's disease through movie materials. Funct Neurol (2011) 0.81

Levodopa/benserazide microsphere (LBM) prevents L-dopa induced dyskinesia by inactivation of the DR1/PKA/P-tau pathway in 6-OHDA-lesioned Parkinson's rats. Sci Rep (2014) 0.80

Long-Term Treatment with Extended-Release Carbidopa-Levodopa (IPX066) in Early and Advanced Parkinson's Disease: A 9-Month Open-Label Extension Trial. CNS Drugs (2015) 0.79

Spontaneous locomotor activity and L-DOPA-induced dyskinesia are not linked in 6-OHDA parkinsonian rats. Front Behav Neurosci (2014) 0.79

Does WOQ-9 help to recognize symptoms of non-motor wearing-off in Parkinson's disease? J Neural Transm (Vienna) (2011) 0.78

Deep brain stimulation in late stage Parkinson's disease: a retrospective cost analysis in Germany. J Neurol (2005) 0.78

Medical healthcare use in Parkinson's disease: survey in a cohort of ambulatory patients in Italy. BMC Health Serv Res (2005) 0.78

Real life cost and quality of life associated with continuous intraduodenal levodopa infusion compared with oral treatment in Parkinson patients. J Neurol (2014) 0.76

Effects and molecular mechanism of chitosan-coated levodopa nanoliposomes on behavior of dyskinesia rats. Biol Res (2016) 0.75

Do neurologists in Germany adhere to the national Parkinson's disease guideline? Neuropsychiatr Dis Treat (2011) 0.75

Behind the mask : a study on the clinical course, psychopathology and impact on quality of life in idiopathic Parkinson's disease. Indian J Psychiatry (2004) 0.75

Articles by these authors

(truncated to the top 100)

Genetic organization and diversity of the hepatitis C virus. Proc Natl Acad Sci U S A (1991) 14.05

Neurostimulation for Parkinson's disease with early motor complications. N Engl J Med (2013) 6.37

Vaccination of chimpanzees against infection by the hepatitis C virus. Proc Natl Acad Sci U S A (1994) 3.76

Expression, identification and subcellular localization of the proteins encoded by the hepatitis C viral genome. J Gen Virol (1993) 3.18

The role of radiotracer imaging in Parkinson disease. Neurology (2005) 3.02

The hepatitis C virus encodes a serine protease involved in processing of the putative nonstructural proteins from the viral polyprotein precursor. Biochem Biophys Res Commun (1993) 2.67

Characterization of hepatitis C virus envelope glycoprotein complexes expressed by recombinant vaccinia viruses. J Virol (1993) 2.58

Characterization of the hepatitis C virus E2/NS1 gene product expressed in mammalian cells. Virology (1992) 2.58

Prevalence of Parkinson's disease in Europe: A collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group. Neurology (2000) 2.45

Progressive degeneration of nigrostriatal dopamine neurons following intrastriatal terminal lesions with 6-hydroxydopamine: a combined retrograde tracing and immunocytochemical study in the rat. Neuroscience (1994) 2.40

Gastric distention: a mechanism for postprandial gastroesophageal reflux. Gastroenterology (1985) 2.37

Prevalence and risk factors of RLS in an elderly population: the MEMO study. Memory and Morbidity in Augsburg Elderly. Neurology (2000) 2.34

Serum C-reactive protein is linked to cerebral microstructural integrity and cognitive function. Neurology (2010) 2.21

Diagnosis of hepatitis C virus (HCV) infection using an immunodominant chimeric polyprotein to capture circulating antibodies: reevaluation of the role of HCV in liver disease. Proc Natl Acad Sci U S A (1992) 2.18

Intravenous immunoglobulins containing antibodies against beta-amyloid for the treatment of Alzheimer's disease. J Neurol Neurosurg Psychiatry (2004) 2.12

Accurate differentiation of parkinsonism and essential tremor using visual assessment of [123I]-FP-CIT SPECT imaging: the [123I]-FP-CIT study group. Mov Disord (2000) 2.10

Possible environmental, occupational, and other etiologic factors for Parkinson's disease: a case-control study in Germany. Neurology (1996) 2.01

Healing of arterial prostheses in man: its incompleteness. Ann Surg (1972) 1.97

Intravenous levetiracetam in the treatment of benzodiazepine refractory status epilepticus. J Neurol Neurosurg Psychiatry (2007) 1.80

Association of an interleukin 1 alpha polymorphism with Alzheimer's disease. Neurology (2000) 1.76

Static mechanical hyperalgesia without dynamic tactile allodynia in patients with restless legs syndrome. Brain (2004) 1.75

Combination of 'idiopathic' REM sleep behaviour disorder and olfactory dysfunction as possible indicator for alpha-synucleinopathy demonstrated by dopamine transporter FP-CIT-SPECT. Brain (2004) 1.74

Regional variability in the prevalence of cerebral white matter lesions: an MRI study in 9 European countries (CASCADE). Neuroepidemiology (2005) 1.70

Body mass index, migraine, migraine frequency and migraine features in women. Cephalalgia (2009) 1.69

DTI reveals hypothalamic and brainstem white matter lesions in patients with idiopathic narcolepsy. Sleep Med (2012) 1.68

Diet and Parkinson's disease. II: A possible role for the past intake of specific nutrients. Results from a self-administered food-frequency questionnaire in a case-control study. Neurology (1996) 1.68

Radio imaging of the very-high-energy gamma-ray emission region in the central engine of a radio galaxy. Science (2009) 1.66

The combination of hypointense and hyperintense signal changes on T2-weighted magnetic resonance imaging sequences: a specific marker of multiple system atrophy? Arch Neurol (1999) 1.66

Exercise and risk of stroke in male physicians. Stroke (1999) 1.65

Very-high-energy gamma rays from a distant quasar: how transparent is the universe? Science (2008) 1.65

Regional differences in the prevalence of known Type 2 diabetes mellitus in 45-74 years old individuals: results from six population-based studies in Germany (DIAB-CORE Consortium). Diabet Med (2012) 1.56

Five subtypes of type A gamma-aminobutyric acid receptors identified in neurons by double and triple immunofluorescence staining with subunit-specific antibodies. Proc Natl Acad Sci U S A (1992) 1.55

A point mutation in PTPRC is associated with the development of multiple sclerosis. Nat Genet (2000) 1.54

Effective cabergoline treatment in idiopathic restless legs syndrome. Neurology (2004) 1.51

Perineuronal nets provide a polyanionic, glia-associated form of microenvironment around certain neurons in many parts of the rat brain. Glia (1993) 1.49

Incidence of status epilepticus in adults in Germany: a prospective, population-based study. Epilepsia (2001) 1.49

CNS involvement in hereditary neuropathy with pressure palsies (HNPP). Neurology (2006) 1.44

Coexistence of galanin-like immunoreactivity with catecholamines, 5-hydroxytryptamine, GABA and neuropeptides in the rat CNS. J Neurosci (1986) 1.43

Double-blind crossover trial of trimethoprim-sulfamethoxazole in spinocerebellar ataxia type 3/Machado-Joseph disease. Arch Neurol (2001) 1.42

Variable very-high-energy gamma-ray emission from the microquasar LS I +61 303. Science (2006) 1.40

Production of a specific antiserum to rat brain glutamic acid decarboxylase by injection of an antigen-antibody complex. Neuroscience (1981) 1.40

An external velour surface for porous arterial prostheses. Surgery (1971) 1.32

Activation mapping in essential tremor with functional magnetic resonance imaging. Ann Neurol (1997) 1.30

Patterns of cerebrospinal fluid pathology correlate with disease progression in multiple sclerosis. Brain (2001) 1.30

Histologic fate and endothelial changes of distended and nondistended vein grafts. Ann Surg (1976) 1.25

The preclotting of porous arterial prostheses. Ann Surg (1978) 1.25

Men and women are different: diffusion tensor imaging reveals sexual dimorphism in the microstructure of the thalamus, corpus callosum and cingulum. Neuroimage (2010) 1.24

Summary of the recommendations of the EFNS/MDS-ES review on therapeutic management of Parkinson's disease. Eur J Neurol (2013) 1.24

Headache prevalence among adolescents--the German DMKG headache study. Cephalalgia (2007) 1.24

Cerebral generators involved in the pathogenesis of the restless legs syndrome. Ann Neurol (1997) 1.23

The impact of regional deprivation and individual socio-economic status on the prevalence of Type 2 diabetes in Germany. A pooled analysis of five population-based studies. Diabet Med (2013) 1.21

Starnberg trial on epidemiology of Parkinsonism and hypertension in the elderly. Prevalence of Parkinson's disease and related disorders assessed by a door-to-door survey of inhabitants older than 65 years. Arch Neurol (1995) 1.21

Hepatitis C virus core and E2 protein expression in transgenic mice. Hepatology (1997) 1.20

Bilateral caudate and putamen grafts of embryonic mesencephalic tissue treated with lazaroids in Parkinson's disease. Brain (2000) 1.18

The impact of delayed chemotherapy-induced nausea and vomiting on patients, health resource utilization and costs in German cancer centers. Ann Oncol (2004) 1.18

Catechol-O-methyltransferase inhibition with tolcapone reduces the "wearing off" phenomenon and levodopa requirements in fluctuating parkinsonian patients. J Neurol Neurosurg Psychiatry (1997) 1.17

Effect of high-fat diet, surrounding temperature, and enterostatin on uncoupling protein gene expression. Am J Physiol Endocrinol Metab (2000) 1.16

Efficacy, safety, and tolerance of the non-ergoline dopamine agonist pramipexole in the treatment of advanced Parkinson's disease: a double blind, placebo controlled, randomised, multicentre study. J Neurol Neurosurg Psychiatry (1999) 1.16

Cell-specific immuno-probes for the brain of normal and mutant Drosophila melanogaster. I. Wildtype visual system. Cell Tissue Res (1988) 1.16

Presence of endothelium in an axillary-femoral graft of knitted Dacron with an external velour surface. Ann Surg (1975) 1.15

Motor cortex excitability in focal epilepsies not including the primary motor area--a TMS study. Brain (2005) 1.12

Cost of illness of atopic asthma and seasonal allergic rhinitis in Germany: 1-yr retrospective study. Eur Respir J (2003) 1.12

Hypertension and borderline isolated systolic hypertension increase risks of cardiovascular disease and mortality in male physicians. Circulation (1997) 1.11

Health-related quality of life in subjects with and without Type 2 diabetes: pooled analysis of five population-based surveys in Germany. Diabet Med (2012) 1.11

Late fiber deterioration in Dacron arterial grafts. Ann Surg (1981) 1.10

Evaluation of single nucleotide polymorphisms in the phosphodiesterase 4D gene (PDE4D) and their association with ischaemic stroke in a large German cohort. J Neurol Neurosurg Psychiatry (2006) 1.08

Regional variations in the prevalence of migraine and tension-type headache applying the new IHS criteria: the German DMKG Headache Study. Cephalalgia (2008) 1.08

Evaluation of hepatitis C virus glycoprotein E2 for vaccine design: an endoplasmic reticulum-retained recombinant protein is superior to secreted recombinant protein and DNA-based vaccine candidates. J Virol (2000) 1.07

Surface thrombogenicity of arterial prostheses. Surg Gynecol Obstet (1973) 1.06

1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity in non-human primates is antagonized by pretreatment with nimodipine at the nigral, but not at the striatal level. Brain Res (1996) 1.06

Prevalence of chronic migraine and medication overuse headache in Germany--the German DMKG headache study. Cephalalgia (2010) 1.06

The economic burden of hepatitis B in Germany. Eur J Epidemiol (2000) 1.05

Central GABAergic innervation of neurointermediate pituitary lobe: biochemical and immunocytochemical study in the rat. Proc Natl Acad Sci U S A (1982) 1.05

A randomized controlled study of pergolide in patients with restless legs syndrome. Neurology (1999) 1.05

T2 relaxation time in patients with Parkinson's disease. Neurology (1993) 1.05

Immunocytochemical localization of glutamate decarboxylase in rat cerebellum with a new antiserum. Neuroscience (1981) 1.04

Two-color immunohistochemistry for dopamine and GABA neurons in rat substantia nigra and zona incerta. Brain Res Bull (1983) 1.03

Atypical parkinsonism in Guadeloupe: a common risk factor for two closely related phenotypes? Brain (2007) 1.02

The economic impact of Parkinson's disease. An estimation based on a 3-month prospective analysis. Pharmacoeconomics (1998) 1.02

Low-frequency rTMS of the vertex in the prophylactic treatment of migraine. Cephalalgia (2010) 1.01

Topiramate, nutrition and weight change: a prospective study. J Neurol Neurosurg Psychiatry (2007) 1.00

Mutation analysis and association studies of the UCHL1 gene in German Parkinson's disease patients. Neuroreport (2000) 0.98

Recommendations concerning the use of bacterial collagenase for isolating collagen-associated molecules from tissues. Anal Biochem (1973) 0.98

Late-onset myoclonic epilepsy in Down's syndrome (LOMEDS). Seizure (2002) 0.98

[11C]raclopride and positron emission tomography in previously untreated patients with Parkinson's disease: Influence of L-dopa and lisuride therapy on striatal dopamine D2-receptors. Neurology (1994) 0.97

The relationship between subtypes of depression and cardiovascular disease: a systematic review of biological models. Transl Psychiatry (2012) 0.97

Long-term changes of striatal dopamine D2 receptors in patients with Parkinson's disease: a study with positron emission tomography and [11C]raclopride. Mov Disord (1997) 0.97

Olfactory dysfunction in patients with narcolepsy with and without REM sleep behaviour disorder. Brain (2007) 0.97

Burden of pulmonary arterial hypertension in Germany. Respir Med (2010) 0.97

Longitudinal study of the socioeconomic burden of Parkinson's disease in Germany. Eur J Neurol (2010) 0.97

Clinical and biochemical findings in uremic patients with and without restless legs syndrome. Am J Kidney Dis (1998) 0.97

Evidence for estrogen-receptive GABAergic neurons in the preoptic/anterior hypothalamic area of the rat brain. Neuroendocrinology (1986) 0.96

Effects of transcranial direct current stimulation on pain perception and working memory. Eur J Pain (2012) 0.96

Development and evaluation of the Parkinson Psychosis Questionnaire A screening-instrument for the early diagnosis of drug-induced psychosis in Parkinson's disease. J Neurol (2005) 0.96

Pharmacotherapy of Parkinson's disease in Germany. J Neurol (2005) 0.96

Clinical symptoms and possible anticipation in a large kindred of familial restless legs syndrome. Mov Disord (1996) 0.96

Pregabalin-induced generalized myoclonic status epilepticus in patients with chronic pain. Epilepsy Behav (2007) 0.95

Pretreatment with nimodipine prevents MPTP-induced neurotoxicity at the nigral, but not at the striatal level in mice. Neuroreport (1995) 0.95

Coexistence of glutamic acid decarboxylase- and somatostatin-like immunoreactivity in neurons of the feline nucleus reticularis thalami. J Neurosci (1983) 0.95

Health resource consumption and costs attributable to chemotherapy-induced toxicity in German routine hospital care in lymphoproliferative disorder and NSCLC patients. Ann Oncol (2011) 0.95